Targeting chemokine interactions and subsequent recruitment of macrophages within tumors, including the CCL2/CCR2 or CXCL12/CXCR4/7 chemokine-chemokine receptor axes, have shown great potential for cancer therapies in various mouse models of cancer metastasis [96,97,98]. The gene discussed is CCR2; the disease is cancer.